Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study
โ Scribed by W. Milano; C. Petrella; A. Casella; A. Capasso; S. Carrino; L. Milano
- Publisher
- Springer Healthcare Communications
- Year
- 2005
- Tongue
- English
- Weight
- 333 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective: This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders. ## Method: In this 12โweek, doubleโblind, placeboโcontrolled trial, 40 patients with Diagnostic and Statistical Manual of Mental DisordersโIVโTR B
## Abstract ## Objective The purpose of this study was to evaluate the efficacy and safety of highโdose escitalopram in the treatment of bingeโeating disorder (BED) associated with obesity. ## Method Fortyโfour outpatients with BED by DSMโIV criteria and obesity were randomized to receive either
Canine acral lick dermatitis (ALD) has been suggested as an animal analogue of obsessive-compulsive disorder (OCD). A series of dogs with ALD or similar conditions were treated with citalopram, the most selective of the selective serotonin reuptake inhibitors. Six of nine (66.7%) dogs showed signifi